News / Health

Quest Continues for HIV Vaccine

Scientists continue to press forward and have made some promising discoveries in developing a vaccine against HIV, the virus that causes AIDS
Scientists continue to press forward and have made some promising discoveries in developing a vaccine against HIV, the virus that causes AIDS

Multimedia

Jeff Swicord

In May of 1997, U.S. President Bill Clinton set the goal of developing a vaccine against HIV, the virus that causes AIDS, within 10 years.   The Vaccine Research Center at the National Institute of Health was established to help achieve the ambitious goal.  That decade has come and gone with no HIV vaccine.  But, scientists are tirelessly pressing forward and have made some promising discoveries.

Like many medical practitioners specializing in HIV/AIDS treatment, Dr. Raymond Martins with the Whitman Walker Clinic in Washington is frustrated by the lack of progress toward an HIV vaccine.

The United Nations says more than 30 million people worldwide are living with HIV.  Powerful drugs can now limit the damage the virus can do to the human immune system.  But neutralizing or preventive vaccines remains elusive.

“HIV mutates quickly and it is also highly variable in the protein that it expresses on its coat, so because of that, it makes it very difficult to form an effective vaccine,” Dr. Martins said.

Dr. Gary Nabel, has been director of the Vaccine Research Center at the National Institutes of Health, since its founding 12 years ago.  He, too, sees the AIDS virus as a tough adversary, with unique features that make vaccine development difficult.

“One is that it is moving, genetically," he said.  "And what I mean by that is that every time the virus divides, the genetic makeup of the virus changes and you end up with different forms of the virus.  So, it is constantly mutating.  And what that means is that it gives it more chance to escape from the human antibody [immune system] response.”

Another feature of HIV is that proteins on the surface of the virus are constantly moving, almost like a tree branch swaying back and forth in a stiff wind.  The proteins are also coated with sugars that mask their identity.   The result is the immune system never has a stationary target to attack.

“And so that movement, that camouflage by sugars, make it very difficult for the immune system to even see the parts of the virus that we would want to target,” Dr. Nable said.

In the past year, the Vaccine Research Center has made a promising discovery.  They have successfully targeted a known vulnerability in the virus, a part that never changes, with antibodies taken from HIV-infected humans.  More importantly researchers have cloned these antibodies in the laboratory.

“These antibodies that come from HIV-infected individuals can recognize and neutralize over 90 percent of the naturally circulating [HIV] strains," Dr. Nabel said.  "That is something that we didn’t know even a year ago.  And it really identifies a target for vaccine development that is fixed and is vulnerable and we know humans can recognize and respond too.”

Dr. Nabel cautions that this new approach to an HIV vaccine is in its preliminary stages.  Even if all goes well, which is rare, success could be many years away.  For now, though, there is a glimmer of hope.

“I would be the last person to tell you that it will be done before it is done," he said.  "I think we need to prove it and we need to get things across the finish line.  But I do think we are in a fundamentally different situation than we have been in the past.”

You May Like

EU Court Fines Poland for Hosting CIA 'Black Sites'

Ruling is first time a court has acknowledged suspects were held and tortured at the sites, under US program launched following the 9/11 terrorist attacks More

Migrant Issues Close to Home Spur Groups to Take Action

Groups placing water, food in the desert, or aiding detainees after release, have one common goal: no more deaths of migrants crossing illegally into the US More

Video At AIDS Conference, Prevention Pill Stirs Excitement

Truveda shows promise, spurring debate over access and other approaches More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Treatment for Childhood Epilepsy Heats up Medical Marijuana Debatei
X
Shelley Schlender
July 24, 2014 6:43 PM
In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video Death Toll From Israel-Gaza Conflict Surpasses 700

Gaza officials say a shelling hit a compound housing a United Nations-run school in the Gaza Strip, killing more than a dozen people, during an Israeli offensive in the area. Heavy fighting between the Israeli military and Hamas militants continued on Thursday, pushing up the death toll. So far, more than 730 Palestinians and 35 Israelis have been killed in the conflict. VOA's Scott Bobb has the latest from Jerusalem.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video Israel Targets Gaza Supply Tunnels

The Israeli military has launched a ground operation in Gaza to destroy the myriad tunnels that may have been used to smuggle weapons to Hamas. VOA's Zlatica Hoke reports that could mean more hardship for the people of Gaza, who obtain some of their essential supplies through these underground passages
Video

Video Researchers Target Low-Cost Avatar Technology

Scientists at the University of Southern California Institute for Creative Technologies say 3-dimensional representations could revolutionize social media. Elizabeth Lee has more from Los Angeles.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.

AppleAndroid